Survival Probabilities of Pediatric Patients Registered in Art Centre at New Civil Hospital, Surat
Keywords:
Paediatric HIV, Survival probability, Kaplan-Meier, WHO stagingAbstract
Aims and Objectives: To study the profile of paediatric HIV patients registered in ART centre of New Civil Hospital, Surat, Gujarat (India) and provide an estimate of 3 years survival probabilities of paediatric HIV patients on ART.
Material and methods: Data of 175 paediatric patients (of age less than 15 years), registered from 2007 to 2010 was collected and analyzed. Kaplan Meir method for survival analysis and Log rank test to test statistical significance were used.
Observations: Survival analysis of 161 patients could be done (registered from Oct 2006 to Oct 2010). The survival probability after 8 years of diagnosis of HIV is 91.7 %. After 3 year of start of ART according to WHO criteria survival probability is 85.7 %. The 3-year survival rate of paediatric HIV patients with WHO Stage 1 is 100%, Stage 2 is 75%, Stage 3 is 61.9% and Stage 4 is 40.8% which was statistically significant (p < 0.001).
Conclusions: The survival probability was 91% after 3 years of diagnosis of HIV and remained same till 8 years and the probability was independent of age groups and sex. The survival probability was 85.7 % after 3 years of start of ART. There was no difference in survival probability with different baseline CD4 counts but was significantly low in patients who were in WHO stage 3 and 4 at the time of registration.
Recommendations: With ART definitely proving increase in survival probability, it is now time to study different drug regimens and their respective survival probabilities. There are many studies on adverse effects of the ART drugs but there is need for research on their effect on survival. There is a scope for continuing of this study further with at least median follow up of 5 years. Larger sample and regression model can be used to understand more precisely the predictors of survival.
References
UNAIDS. Report On The Global AIDS Epidemic. Geneva, Switzerland 2010, p8
NACO, Department of AIDS Control, Ministry of Health & Family Welfare Annual Report 2009-2010, Janpath, New Delhi: NACO 2009-10, p1.
UNAIDS. UNAIDS World AIDS Day Report 2011 - How to get zero: Faster. Smarter. Better. 2011. Geneva, Switzerland: UNAIDS 2011, p6.
UNICEF Eastern and Southern Africa - HIV and AIDS - Preventing mother-to-child transmission (PMTCT) of HIV - Providing Paediatric Treatment cited on 12, Dec 2012.
Violari A, Cotton MF, Gibb DM, Babiker AG, Steyn J, Madhi S a, et al. Early antiretroviral therapy and mortality among HIV-infected infants. The New England journal of medicine [Internet]. 2008 Nov 20;359 (21):2233–44.
Isaakidis P, Raguenaud M-E, Te V, Tray CS, Akao K, Kumar V, et al. High survival and treatment success sustained after two and three years of first-line ART for children in Cambodia. Journal of the International AIDS Society [Internet]. 2010 Jan;13:11.
Alibhai A, Kipp W, Saunders LD, Senthilselvan A, Kaler A, Houston S, et al. Gender-related mortality for HIV-infected patients on highly active antiretroviral therapy (HAART) in rural Uganda. International journal of women’s health [Internet]. 2010 Jan;2:45–52.
Novaes A, Jr R. Improving survival in children with AIDS in Brazil : results of the second national Ampliação da sobrevida em crianças com AIDS no Brasil : resultados do segundo estudo nacional de 1999 a 2002. Social Sciences. 2011;1999–2002.
O’Brien DP, Sauvageot D, Olson D, Schaeffer M, Humblet P, Pudjades M, et al. Treatment outcomes stratified by baseline immunological status among young children receiving non-nucleoside reverse-transcriptase inhibitor-based antiretroviral therapy in resource-limited settings. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Internet]. 2007 May 1 [cited 2012 Apr 21]; 44(9):1245–8.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
The authors retain the copyright of their article, with first publication rights granted to Medsci Publications.